Resistance Training in Elderly

Aging Clinical Trial

Official title:

The Influence of Resistance Training on Body Composition and Muscle Characteristics in Healthy Elderly

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00744094
• Other study ID #: MEC 06-3-062B
• Status: Completed
• Phase: Phase 1/Phase 2
• First received: August 28, 2008
• Last updated: September 22, 2015
• Start date: January 2007
• Est. completion date: July 2008

Study information

• Verified date: August 2008
• Source: Maastricht University Medical Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
• Study type: Interventional

Clinical Trial Summary

In the present study the investigators aim to determine whether protein supplementation can augment the response to a 12 week resistance training program in healthy elderly men.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 26
• Est. completion date: July 2008
• Est. primary completion date: September 2007
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 65 Years to 85 Years

Eligibility

Inclusion Criteria:

• Living independently

Exclusion Criteria:

• Diabetes

• Cardiovascular disease

• Orthopedic limitations

• Any disorder known to compromise ability for resistance training

• History of resistance training in past 5 years

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Aging
• Atrophy
• Sarcopenia

Intervention

Dietary Supplement:
• protein drink
250 ml protein hydrolysate solution

Behavioral:
• Resistance training
12 weeks resistance training, 3 days per week

Locations

Country	Name	City	State
Netherlands	Maastricht University	Maastricht

Sponsors (3)

Lead Sponsor	Collaborator
Maastricht University Medical Center	DSM Food Specialties, The Anna Foundation

Country where clinical trial is conducted

Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Muscle mass measured at limb and cellular level		before and after 12 weeks of intervention	No
Secondary	Muscle strength		before and after 12 weeks of intervention	No
Secondary	Body composition		before and after 12 weeks of intervention	No